How to interpret immunohistochemical results for cervical cancer

The immunohistochemical results for cervical cancer primarily focus on the following key markers: 1. HPV E6, E7: These markers reflect the expression of oncogenic HPV genes. A negative result is normal, while high-level expression may be associated with the development of cervical cancer and requires further evaluation. 2. P16, P53: P16 is a tumor suppressor gene, and P53 is a cell cycle regulatory protein. Overexpression of P16 and mutations in P53 are both closely associated with the development and progression of cervical cancer. High expression levels suggest the presence or progression of cervical cancer. 3. Ki-67: This marker is related to cell proliferation. A level below 15% indicates low tumor cell proliferation activity, whereas a level above 15% suggests active proliferation. In summary, immunohistochemical analysis of these markers helps physicians assess the expression of specific antigens in cervical cells, thereby aiding in diagnosis and prognosis evaluation. When necessary, further treatment should be determined based on clinical presentation and the recommendations of the treating physician.